Scarcity, Geography Will Shape COVID-19 Vaccine Rollout

The rollout of a vaccine for SARS-CoV-2, the virus that causes COVID-19, is an unprecedented logistical challenge. So will be deciding who gets it: experts say that the initial vaccine supply will not be large enough to dose everyone who wants it — and payers and PBMs will have a large role to play in distributing the medicine to the right people quickly.

David Simchi-Levi, Ph.D., a systems engineer who studies manufacturing and supply chain at MIT, tells AIS Health that it’s inevitable that vaccine supply will not meet demand when it is available.

© 2023 MMIT
Peter Johnson

Peter Johnson

Peter has been a reporter for nearly a decade. Before joining AIS Health, Peter covered a wide variety of topics in his hometown of Seattle, where he continues to live. Peter’s work has appeared in publications including The Atlantic and The Stranger. Peter attended Colby College.

Related Posts

pills-in-dollar-sign
September 28

Retail Prescription Drug Spending Growth May Slow Down in Next Decade

READ MORE
businessman-viewing-news-update-journalism-headline-on-a-laptop
September 28

News Briefs: Independent Pharmacists Seek ‘Payback’ From PBMs in CVS Lawsuit

READ MORE
person-leaning-out-of-line
September 28

‘Transparency-Rx’ Execs Explain Why They’re Breaking Rank, Backing PBM Reform

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today